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Abstract: Multi-step cascade reactions have gained increasing attention in the biocatalysis field in
recent years. In particular, multi-enzymatic cascades can achieve high molecular complexity without
workup of reaction intermediates thanks to the enzymes’ intrinsic selectivity; and where enzymes
fall short, organo- or metal catalysts can further expand the range of possible synthetic routes. Here,
we present two enantiocomplementary (chemo)-enzymatic cascades composed of either a styrene
monooxygenase (StyAB) or the Shi epoxidation catalyst for enantioselective alkene epoxidation in the
first step, coupled with a halohydrin dehalogenase (HHDH)-catalysed regioselective epoxide ring
opening in the second step for the synthesis of chiral aliphatic non-terminal azidoalcohols. Through
the controlled formation of two new stereocenters, corresponding azidoalcohol products could be
obtained with high regioselectivity and excellent enantioselectivity (99% ee) in the StyAB-HHDH
cascade, while product enantiomeric excesses in the Shi-HHDH cascade ranged between 56 and 61%.
Keywords: biocatalysis; enzymatic cascade; stereoselectivity; regioselectivity; azidoalcohols; halohy-
drin dehalogenase; monooxygenase
1. Introduction
Biocatalytic and chemo-enzymatic cascade reactions have gained a lot of attention
in recent years due to their environmental benefits and the ability to achieve high prod-
uct yields and enantiomeric excesses over multi-step synthetic routes [1]. Their main
advantages are (i) the avoidance of intermediate workup steps and (ii) the possibility to
include unstable intermediates that are directly converted further in the next (bio)catalytic
step [1–3]. However, these advantages are accompanied by new challenges arising from
the combination of catalysts that require more or less different reaction conditions. Herein,
we describe two (chemo)-enzymatic cascades for the synthesis of opposite enantiomers of
2,3-azidoalcohols starting from simple non-terminal alkenes (Scheme 1).
Compounds containing an azido group have a particular synthetic importance, and
they caught the attention of organic chemists already in the previous century. They are
key intermediates for the synthesis of aminoalcohols [4–6], lactams [7], amino sugars [8],
oxazolines [9], and are important in the synthesis of carbohydrates and nucleosides [10,11].
So far, not many examples of chemo-enzymatic cascades to synthesise azidoalcohols
are described. In a recent example, Martínez-Montero et al. reported a (chemo)-enzymatic
cascade for the synthesis of aromatic α- and β-azidoalcohols. They coupled a styrene
monooxygenase from Sphingopyxis fribergensis Kp5.2 either with chemical epoxide azidoly-
sis or a set of HHDHs to synthesise different isomers of styrene-based azidoalcohols with
high enantiopurity [12].
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Here, we aimed to find a synthetic pathway towards enantiopure aliphatic azidoalco-
hols starting from more challenging linear alkenes as substrate. For this, we also coupled a
stereoselective alkene epoxidation step with a regioselective epoxide ring-opening using
azide to afford opposite enantiomers of model 2,3-azidoalcohols with the installation and
control of two new stereocenters (Scheme 1).
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epoxidation, high selectivity can be achieved mostly towards cis-di-substituted olefins [17],
whereas selectivity towards trans-olefins was found to be low [18,19]. Dioxirane can per-
form epoxidations of olefines as well, and the enantioselectivity can be controlled by a
chiral environment in the dioxirane’s surroundings. The most notable example is the Shi
epoxidation [20], which makes use of a carbohydrate-derived rigid scaffold to enhance enan-
tioselectivity [14]. This fructose-derived ketone (Shi epoxidation diketal catalyst), when
activated by an oxidative agent such as Oxone© or H2O2, shows optimal performance with
unfunctionalised trans-olefins in contrast to the Jacobsen catalysts (i.e., (salen)manganese
complexes) [20,21]. Compared to those chemical approaches, nature has evolved different
oxidative enzymes to perform asymmetric epoxidations of olefins using molecular oxy-
gen. The most popular ones are monooxygenases, oxidases, and peroxygenases [22–24].
Among these, styrene monooxygenases have gained attention for their extremely high
stereoselectivity in the epoxidation of C=C bonds. The substrate scope of these enzymes is
generally limited to vinyl aromatic compounds with few exceptions [25,26]. However, a
recently characterised styrene monooxygenase from Rhodococcus sp. ST-10, was found to
convert also short-chain aliphatic alkenes with good performance [27]. Interestingly, most
known enzymes preferentially produce (S)- or (S,S)-epoxide enantiomers [26,28–30], while
(R)-selective styrene monooxygenases have only been reported very recently [31–33].
Epoxide ring-opening is a common reaction that has been used in organic synthesis
for many years. Azidoalcohols are generally synthesised by azidolysis of epoxides in
aqueous alcohol systems. However, this type of reaction requires high temperatures
and long reaction times and no regio- or stereoselectivity is observed [11]. Due to the
high value of some azidoalcohols, few methodologies were found to overcome such
limitations. Among these, diethylaluminium azide is one of the most popular catalysts
as it displays regioselectivity that is independent from the epoxide ring’s substitutents;
however, this process is highly specific for 2,3-epoxyalcohols as substrates and often
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results in a considerable formation of 3-chloro-1,2-diols as side products [34]. Moreover,
trimethylsilylazide in the presence of chiral (salen)Cr3+ complexes [35], similar to the
Jacobsen catalysts for epoxidation, or β-cyclodextrin [36] could achieve high regio- and
enantioselectivity in the azidolysis of terminal or cyclic epoxides. However, their molecular
complexity and price constitute major limitations [35,37,38].
In contrast, a group of enzymes called halohydrin dehalogenases (HHDH) catalyse
epoxide ring-opening reactions under mild conditions in the presence of different anionic
nucleophiles such as N3−, CN−, and NO2−. Hence, HHDHs are particularly attractive
in biocatalysis as they enable the formation of novel C-N, C-C, or C-O bonds without
cofactor requirement [39,40]. Additionally, recent work on expanding the number of
known HHDHs [41] in combination with the characterisation of new members showed that
a wide range of epoxide substrates can be converted by HHDHs [42,43]. Depending on the
individual enzyme and substrate to be converted, also high regio- and enantioselectivity
can be achieved. In particular, members of subtype E were reported to display high
regioselectivity in the epoxide ring-opening of aliphatic non-terminal epoxides, as desired
in our cascade [42].
In order to obtain chiral non-terminal azidoalcohols from achiral alkenes, we herein
aimed to control the formation of the two new stereocenters through the combination of
an asymmetric, either chemical or enzymatic epoxidation and a regioselective, HHDH-
catalysed epoxide ring-opening using azide.
2. Results and Discussion
2.1. Catalyst Selection for Asymmetric Epoxidation (First Cascade Step)
Initially, a set of chemical and enzyme catalysts was tested in the epoxidation of
trans-2-heptene (4) as a model substrate. In particular, the styrene monooxygenase from
Rhodococcus sp. ST-10, the unspecific peroxygenase from A. aegerita, the Shi epodixation
diketal catalyst, and both (R,R)- and (S,S)-enantiomers of the Jacobsen catalyst were tested
on an analytical scale (1 mL) for the conversion of 5 mM substrate using the respective
optimal conditions described in the literature (see the Methods section for details).
Among the tested catalysts, only two achieved a conversion ≥ 50% and a product
enantiomeric excess (eeP) higher than 90% (Figure 1). Specifically, the styrene monooxyge-
nase synthesised the (S,S)-epoxide with an eeP > 95%, whereas the Shi epoxidation diketal
catalyst produced the opposite epoxide enantiomer with an eeP > 90%. The remaining
catalysts displayed a conversion below 5% and insufficient selectivity. The identification
of two epoxidation catalysts with opposite enantioselectivity opened up the possibility to
synthesise opposite enantiomers of the final azidoalcohol products (Scheme 1).
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HheE appeared to be the best enzyme in the epoxide ring-opening of trans-2,3-
epoxyhexane (2) (Figure 2), whereas HheE5 seemed less active with this substrate and did 
not reach full conversion within 24 h. In contrast, HheE5 was faster in the conversion of 
trans-2,3-epoxyheptane (5) compared to HheE (Figure 2). Both enzymes preferentially 
formed 2-azido-3-hydroxyhexane (3a) and 2-azido-3-hydroxyheptane (6a) as products 
with a regioselectivity of ≥98%, which is in agreement with our previous data [42]. In both 
cases, only traces of the corresponding regioisomers 3-azido-2-hydroxyhexane (3b) and 3-
azido-2-hydroxyheptane (6b) were obtained. Hence, HheE was selected for conversion of 
epoxide 2 in the final cascade, whereas HheE5 was selected for the azidolysis of epoxide 
5. 
 
Figure 2. Conversion of racemic epoxides 2 (left) and 5 (right) using the regioselective HHDHs from 
subtype E as whole cell catalysts (60 g/L, wet cell weight). Each reaction was carried out in duplicate 
using 10 mM substrate, 50 mM NaN3 in 1 mL 50 mM KPi buffer pH 7.5 at 25 °C. 
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2.2. Catalyst Selection for the Epoxide Ring-Opening Reaction (Second Cascade Step)
After enantioselective epoxidation in the first step, a highly regioselective catalyst
was required for ring-opening of the epoxide intermediate to control the production of
only one of the two possible azidoalcohol isomers (Scheme 1, compounds 3a and 6a).
For this, we investigated different HHDHs from subtype E in the conversion of 10 mM
epoxide substrate in the 1 mL scale. These HHDHs had previously been identified as
regioselective towards non-terminal epoxides [42], but further experiments were required
to select the most active one for the conversion of epoxides 2 and 5. The enzymes were
applied as whole cell catalysts (60 g/L, wet cell weight), and HheE as well as HheE5
performed evidently better with both substrates compared to the other three HHDHs.
HheE appeared to be the best enzyme in the epoxide ring-opening of trans-2,3-epoxyhexane
(2) (Figure 2), whereas HheE5 seemed less active with this substrate and did not reach
full conversion within 24 h. In contrast, HheE5 was faster in the conversion of trans-
2,3-epoxyheptane (5) compared to HheE (Figure 2). Both enzymes preferentially formed
2-azido-3-hydroxyhexane (3a) and 2-azido-3-hydroxyheptane (6a) as products with a
regioselectivity of ≥98%, which is in agreement with our previous data [42]. In both
cases, only traces of the corresponding regioisomers 3-azido-2-hydroxyhexane (3b) and
3-azido-2-hydroxyheptane (6b) were obtained. Hence, HheE was selected for conversion of
epoxide 2 in the final cascade, whereas HheE5 was selected for the azidolysis of epoxide 5.
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2.3. Optimisation and Compatibility Tests of the Shi Epoxidation and the HHDH-Catalysed
Epoxide Ring Opening (Cascade 1)
Compatibility of required reaction conditions of different cascade steps is one of the
main challenges in setting up a cascade reaction. The required reaction conditions for asym-
metric Shi epoxidation are constrained by the necessity to prevent catalyst autoxidation
and consequently decomposition. Shi et al. determined that performing the reaction at low
temperature (−2 ◦C) and at pH > 10 could help to reduce catalyst decomposition [44]. An
additional strategy to decrease catalyst decomposition is to provide the oxidant (Oxone©)
portion-wise during the course of the reaction. Thus, for reaction optimisation, the reaction
volume was increased to 20 mL to make Oxone© feeding possible. To maintain the pH at
11, 1.1 equivalents (relative to Oxone©) of solid K2CO3 were added portion-wise during
Oxone© feeding.
Shi et al. tested different acetonitrile and water mixtures and demonstrated that with
an acetonitrile concentration of only 20% (v/v), the reaction would still occur with high
enantioselectivity and conversion > 95% [44,45]. However, we anticipated that the HHDHs
in the subsequent epoxide ring-opening reaction might still be sensitive to this amount of
organic co-solvent. Hence, different acetonitrile concentrations were tested to determine
their effect on epoxide yield and enantiopurity. As supposed, reactions with 20% (v/v)
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acetonitrile concentration resulted in the best conversion values for both alkene substrates.
At the same time, the product enantiomeric excess decreased to 80–85% compared to
small-scale reactions, where 30% (v/v) acetonitrile had been used (Table 1). Decreasing
the amount of acetonitrile further resulted in significantly lower conversions for both
substrates. However, in general, better conversions were obtained in epoxidation reactions
of trans-2-hexene (1) compared to trans-2-heptene (4) (Table 1). Lowering the acetonitrile
concentration to 10% (v/v) caused a decrease in conversion below 50%, while the product
enantiomeric excess remained around 80–85% (Table 1). Moreover, using only 5% (v/v)
of acetonitrile did not decrease conversion further, while the product enantiomeric excess
dropped to approximately 50%. Possibly, Oxone© is more soluble at lower acetonitrile
concentrations, causing higher auto-oxidation of the Shi diketal epoxidation catalyst. This
auto-oxidation of the catalyst leads to the formation of acetone, which in turn will catalyse
a non-selective alkene epoxidation together with Oxone© [20,44]. Moreover, acetonitrile
has been proposed to participate in the reaction mechanism of the Shi epoxidation [45].
Hence, lower epoxide yields and enantiopurity at reduced acetonitrile concentration are in
agreement with both hypotheses.
Table 1. Conversion and product enantiomeric excess (eeP) obtained in the Shi epoxidation of alkenes
1 and 4 at different acetonitrile concentrations. The epoxidations were carried out at a 20 mL scale,
and K2CO3 was used to maintain the pH at 11; 0.2 equivalents of the Shi epoxidation catalyst and
4 equivalents of Oxone© were used in the conversion of 50 mM substrate.
Substrate Acetonitrile Conversion eeP
trans-2-hexene (1) 20% 78.8% ± 5.8% 85%
trans-2-hexene (1) 10% 26.4% ± 1.8% 80%
trans-2-hexene (1) 5% 26.4% ± 1.8% 45%
trans-2-heptene (4) 20% 41.3% ± 7.6% 81%
trans-2-heptene (4) 10% 24.6% ± 3.6% 82%
trans-2-heptene (4) 5% 36.9% ± 0.7% 53%
Given the extreme reaction conditions required in the Shi epoxidation (high pH
and low temperature), a simultaneous combination of epoxidation and HHDH-catalysed
epoxide ring opening was impossible. Therefore, we focused on a sequential combination
of both steps, as temperature and pH could then be adjusted in between. However, in
such a setup, the reaction components of the first step will still be present during the
second cascade step. Hence, we investigated the sensitivity of halohydrin dehalogenases
HheE and HheE5, applied as whole cells, towards acetonitrile and Oxone©, both reaction
components of the Shi epoxidation (Figure 3). Both enzymes displayed reduced activity in
the presence of 10% (v/v) acetonitrile. In contrast, 5% (v/v) acetonitrile had a significantly
lower effect on HheE, while no difference in terms of conversion compared to the control
reaction without acetonitrile was observed for HheE5. The latter enzyme even displayed
very low residual activity at 20% (v/v) acetonitrile concentration. For comparison, we
also investigated the effect of 5% (v/v) acetonitrile on the activity of HheE5 applied as
cell-free extract. Here, the resulting conversion was slightly lower compared to the reaction
with HheE5 applied as whole cells. This might indicate that the cellular envelope helps
to protect the HHDH against the organic co-solvent. Therefore, we decided to use the
HHDHs as whole-cell catalysts in the final cascade. Moreover, the use of 10% acetonitrile
in the first step seemed to be an acceptable compromise between activity and selectivity for
combination of both steps in a cascade.
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We further expected that residual Oxone© from the Shi epoxidation would interfere
with the HHDH step, as Oxone© was reported to oxidise azide, which is used as a nu-
cleophile in the epoxide ring opening, to form N2 and N2O [46]. Thus, a concentration
of 10 mM Oxone© was tested to determine its effect on the epoxide ring opening using
40 mM azide, assuming that most of the added Oxone© from the first step would either be
consumed in the epoxidation or would spontaneously decompose during the course of
the reaction. A 10 mM concentration of Oxone© reduced the reaction rate of the HheE5-
catalysed reaction, but full conversion was still achieved within 24 h (Figure 3). In case of
HheE, 10 mM Oxone© did not exhibit a negative effect on the reaction rate compared to
the positive control reaction without Oxone©. If all Oxone© present would have reacted
with azide, a theoretical amount of 30 mM azide (3 eq.) would still have been available
for the epoxide ring-opening. The fact that this reduction in azide concentration affected
only the reaction rate of HheE5 and not HheE might indicate a possible difference in the
KM of both enzymes for azide as the nucleophile. When determining the enzyme kinetics
of both HHDHs, indeed, an apparently higher affinity of HheE for azide was observed
compared to HheE5 (Table S1). Overall, for the final cascade, it appears that Oxone© can
negatively affect the subsequent cascade step, i.e., epoxide ring opening. However, most of
the applied Oxone© will have reacted or spontaneously decomposed during epoxidation
and the subsequent pH and temperature adjustment. Therefore, the main limiting factor for
compatibility of Shi epoxidation and HHDH-catalysed epoxide ring opening appears to be
the co-solvent acetonitrile, which seems to be essential for conversion and enantioselectivity
in the Shi epoxidation, while it is detrimental for HHDH activity.
2.4. Optimisation of the Styrene Monooxygenase-Catalysed Epoxidation and Compatibility Tests
with the HHDH-Catalysed Epoxide Ring Opening (Cascade 2)
The styrene monooxygenase (StyAB) from Rhodococcus sp. ST-10 is a two-component
system that requires NADH to provide electrons necessary for oxygen activation at the
bound flavin (FAD) cofactor. In general, monooxygenases are complex systems with
multiple variables required for activity. Moreover, styrene monooxygenases usually display
high activity at low substrate concentrations, while substrate and product inhibition can
occur at higher substrate concentrations [27]. Hence, we considered a number of parameters
to improve epoxide production such as different cofactor regeneration systems, different
enzyme formulations, oxygen input, substrate and/or enzyme feeding, and the use of
a two-phase system to enable the use of high substrate concentrations (50 mM) in the
final cascade.
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First, we tested two possible strategies for cofactor regeneration: (i) applying the bio-
catalyst as whole cells (WC) in combination with glucose for NADH regeneration within the
cell, or (ii) applying the biocatalyst as a cell-free extract in combination with a commercial
cofactor regeneration enzyme such as formate dehydrogenase (FDH) from Candida boidinii,
which uses a cheap co-substrate to regenerate NADH. Cofactor regeneration is usually re-
quired to avoid the stoichiometric addition of expensive NADH. Generally, reactions using
the whole-cell system resulted in lower conversions compared to cell-free extract (CFE)
reactions with FDH-catalysed cofactor regeneration (Supplementary Materials, Figure S1).
However, on a larger scale, the addition of a commercial cofactor regeneration enzyme
gets more costly. Therefore, we tested coexpression together with StyAB of two alco-
hol dehydrogenases from Lactobacillus kefir (LkADH) and Leifsonia sp. S749 (LsADH) for
NADH regeneration. LsADH was chosen as it had been applied together with this styrene
monooxygenase before [47], whereas LkADH is a common alcohol dehydrogenase used for
cofactor regeneration and was tested for comparison [48].
In general, the coexpression of LsADH resulted in higher substrate epoxidation by
StyAB (applied as cell-free extract) compared to the coexpression of LkADH. In fact, only
negligible epoxide amounts could be obtained in a reaction using cell-free extract of coex-
pressed StyAB and LkADH due to the strong overexpression of LkADH and thus dimin-
ished amounts of soluble StyAB during coexpression in E. coli (Supplementary Materials,
Figure S2). In contrast, the coexpression of StyAB and LsADH resulted in more bal-
anced amounts of both soluble enzymes. For comparison, an epoxidation reaction using
StyAB-containing cell-free extract with LkADH added as separate cell-free extract did yield
epoxide product (Supplementary Materials, Figure S3).
Secondly, active oxygen input (using compressed air) was tested to see if StyAB-
catalysed epoxidation could be improved by providing more available oxygen for the
reaction. In general, the availability of dissolved molecular oxygen is highly important
for successful StyAB-catalysed epoxidation, as molecular oxygen is used as the oxygen
donor in the reaction. The requirement for active oxygen input was particularly evident in
reactions with the enzyme applied as a whole-cell catalyst in combination with glucose
for NADH regeneration. Here, the cellular metabolism also consumed oxygen for effi-
cient NADH regeneration and possibly cell growth, resulting in a fast drop in dissolved
oxygen concentration (Supplementary Materials, Figure S4A). In contrast, in a reaction
using cell-free extract with the styrene monooxygenase as the only oxygen consumer,
the concentration of dissolved oxygen decreased less rapidly (Supplementary Materials,
Figure S4A). Using compressed air with a constant flow rate of 3 L/h in a stirred 80 mL
reaction enabled us to keep the dissolved oxygen concentration at a high level throughout
the StyAB-catalysed epoxidation reaction (Supplementary Materials, Figure S4B).
Thirdly, small-scale experiments indicated that the StyA component of StyAB was
already inactivated within 6 h at 30 ◦C (Supplementary Materials, Figure S5), which seems
to be due to the thermal instability of the enzyme. Moreover, StyAB was reported in
previous studies to display substrate and product inhibition [27]. Substrate inhibition can
be mitigated by using a substrate feeding strategy to keep the substrate concentration below
a certain level. Respective portion-wise addition of alkene substrate to the reaction proved
to be beneficial as higher epoxide production was achieved (Supplementary Materials,
Figure S3). Hence, further optimisation tests were performed with reactions using cell-free
extract of coexpressed StyAB and LsADH together with alkene feeding. Similarly, enzyme
instability can be mitigated by feeding the enzyme over time to compensate for loss of
activity instead of providing the full amount of StyAB- and LsADH-containing cell-free
extract from the beginning of the reaction. This improved epoxide production further
(Figure 4).
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Figure 4. Epoxidation of 50 trans-2-heptene (4) catalysed by StyAB at 80 mL scale. The reactions
were performed at 30 ◦C in 50 potassium phosphate buffer pH 7.5 with or without 25% heptane
using CFE containing Sty B and LsADH (9.2 g/L final total protein content). Compressed air was
applied using an HPLC frit to finely disperse air bubbles, and overhead mechanical stirring was
applied (300 rp ). Enzyme and substrate feeding were applied hourly for the first 8 h until the stated
concentration was reached (50 mM substrate and 9.2 g/L total protein content).
Finally, we tested the addition of a second organic phase, acting as substrate and prod-
uct sink, to improve product formation further by alleviating also product inhibition [25,49].
Several organic solvents of different polarity were tested and, in general, solvents with
logP > 4, such as cyclohexane, heptane, and isooctane, improved epoxide production
(Supplementary Materials, Figure S6), whereas the use of more polar organic solvents, such
as thy acetate, pentyl ac tate, or hexyl etate [25], did not yield any epoxide (data not
shown). Heptane was finally chosen as organic solvent for its lower boiling poi t compared
to isooctane. Using heptane (25% v/v) as the second organic phase resulted in a four-fold
increase in product concentration compared to the best StyAB-catalysed reaction without
organic solvent (Figure 4). Overall, the use of an aqueous–organic two-phase system had
the highest positive effect on product formation in the StyAB-catalysed epoxidation among
all variables tested.
Since optimisation of the StyAB-catalysed epoxidation reaction highlighted the need
for a second organic phase, the influence of heptane (25% v/v) on the HHDH-catalyse
epoxide ring-opening reaction had to be investigated as well. The presence of organic
solvent had a considerably negative effect on enzyme activity for both HHDHs applied
as whole cells (Figure 5). Especially HheE achieved only 33% conversion within 24 h
(Figure 5), whereas HheE5 still reached 87% conversion, however, after significantly longer
reaction time compared to the control reaction without heptane (Figure 5). Even though
the StyAB-catalysed epoxidation and the HHDH-catalysed epoxide ring-opening reactions
could in theory be performed simultaneously, the observed reduction of HHDH activity in
the presence of heptane as second organic phase speaks against a simultaneous cascade.
Instead, running both steps in a sequential fashion would at least prevent contact between
the HHDHs and heptane before a critical epoxide concentration is formed.
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Figure 5. Conversi n of each 10 mM epoxide 2 and 5 by HheE and HheE5, respectively, applied as
whole cells in the presence and absence of heptane (25% v/v) as organic phase. All experiments were
performed in duplicate in 50 mM potassium phosphate buffer, pH 7.5 at 25 ◦C.
2.5. C scade Runs
The results of the compatibility tests indicated that both cascades (cascade 1: Shi
epoxidation diketal catalyst + HHDH; cascade : t ) should be performed in a
sequential two-step fashion. Moreover, we decide for cascade 1 to run the Shi epoxidation
with only 10% v/v acetonitrile to limit the negative effect of the co-solvent on the subsequent
HHDH-catalysed step. As a consequence, cascade 1 yielded the final azidoalcohols (2S,3R)-
3a and (2S,3R)-6a with reduced product enantiomeric excess of around 60% (Table 2) due
to insufficient enantioselectivity in the epoxidation reaction (Supplementary Materials,
Table S2), and 30–36% conversion over the two steps. The epoxide ring-opening step even
increased eeP a bit, obviously because of a slight enantioselectivity of both HHDHs [42]. In
contrast, corresponding (2R,3S)-azidoalcohols were obtained with excellent enantiomeric
excess (>99%) in the bi-enzymatic cascade 2 (Table 2), however, at reduced isolated yields
compared to cascade 1. The latter is caused by incomplete conversions in both cascade steps
of cascade 2 (Supplementary Materials, Table S2). Considering the high (50 mM) substrate
concentration used in this cascade, 20% and 39% conversion in the StyAB-catalysed step still
translates into 10 and almost 20 mM, respectively, of formed epoxide product. Moreover,
regioisomers 3a and especially 6a were formed with high regioselectivity in the HHDH-
catalysed step (Table 2). Thus, our StyAB + HHDH cascade for the synthesis of aliphatic 2,3-
azidoalcohols compares favourably, in terms of regioselectivity, with the recently published
cascade for the synthesis of aryl aliphatic azidoalcohols [12].
Table 2. Summary of the cascade runs combining StyAB or the Shi epoxidation diketal catalyst with an HHDH (HheE
or HheE5). Cascades starting from 50 mM trans-2-hexene (1) resulted in the formation of 2-azido-3-hydroxyhexane (3a),
whereas cascades starting from 50 mM trans-2-heptene (4) produced 2-azido-3-hydroxyheptane (6a).









trans-2-hexene (1) Shi, HheE 30.4 60.5 61 97:3
trans-2-heptene (4) Shi, HheE5 35.8 83.9 56 99:1
trans-2-hexene (1) StyAB, HheE 14.2 31.7 >99 92:8
trans-2-heptene (4) StyAB, HheE5 13.7 42.9 >99 99:1
[a] Determined by GC-FID [b] Ratio of formed azidoalcohol regioisomers [see Table 3].
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Table 3. List of compounds used in this work.
Alkenes Epoxides Azidoalcohols
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Overall, the poor organic solvent tolerance of the used HHDHs, HheE and HheE5, 
turned out to be a main limiting factor regarding product yield in both cascades, but also 
enantioselectivity in cascade 1. In the future, this could be addressed by enzyme 
engineering as previously shown for HheC, for which a mutant with high residual activity 
in 50% (v/v) acetonitrile could be generated [50]. Such a solvent-tolerant HHDH would 
enable to run the Shi epoxidation reaction at optimal acetonitrile concentration to improve 
epoxide eeP% and conversion. Furthermore, a solvent-tolerant HHDH would also 
facilitate a simultaneous combination of StyAB-catalysed epoxidation and HHDH-
catalysed epoxide ring opening. This could improve the yield of cascade 2, as the formed 
epoxide product would quickly be further converted to the corresponding azidoalcohol, 
and hence, product inhibition of StyAB would be minimised. Alternatively, instead of 
protein engineering, also immobilisation of the HHDHs might be used to increase their 
solvent tolerance [51–53]. 
Moreover, besides the already mentioned substrate and product inhibition of StyAB, 
the enzyme’s low stability—especially also concerning the StyB subunit [26]—is another 
reason limiting the overall conversion of cascade 2. Even though we tried to overcome 
this by enzyme feeding, the problem could not be completely solved when starting from 
50 mM alkene substrate. Enzyme engineering to further stabilise the monooxygenase, e.g., 
by fusion of subunits StyA and StyB as previously shown for the styrene monooxygenase 
from Pseudomonas sp. [54], or enzyme immobilisation [55], as well as more sophisticated 
reaction engineering could be used in the future to achieve high product formation rates 
even at these high substrate concentrations. The latter was already demonstrated by 
Panke et al., who could produce 388 g of styrene oxide in a 30 L fed-batch reactor using 
growing cells harbouring the styrene monooxygenase from Pseudomonas sp. strain VLB120 
[56].  
3. Materials and Methods 
3.1. Chemicals 
All chemicals were purchased from Sigma Aldrich (Steinheim, Germany), 
AppliChem (Darmstadt, Germany), abcr GmbH (Karlsruhe, Germany), Acros Organics 
(Geel, Belgium), and Carl Roth (Karlsruhe, Germany) in the highest purity available, 
unless otherwise stated. Trans-2-hexene (1) was purchased from Acros Organics (Geel, 
Belgium), and trans-2-heptene (4) was purchased from abcr GmbH (Karlsruhe, Germany). 
The Shi epoxidation diketal catalyst, (R,R)- and (S,S)-Jacobsen catalysts were purchased 
from Sigma Aldrich (Steinheim, Germany). Chemical standards that were not 
commercially available were synthesised according to the following protocols. An 
overview of all substrates, intermediates, and products used in this study is given in Table 
3. 
trans- - e e e (1)
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Catalysts 2021, 11, 982 11 of 18
3.2. Chemical Synthesis of Epoxides
The racemic epoxides trans-2,3-epoxyhexane (2) and trans-2,3-epoxyheptane (5) were
synthesised from the corresponding alkenes using meta-chloroperbenzoic acid (m-CPBA)
through a slightly modified protocol from Sharma et al. [57]. Epoxidations were carried
out in CH2Cl2 (40 mL/g of alkene). m-CPBA (1.5 eq.) was added in small portions over
15 min at RT. After 1 h at room temperature, the mixture was stirred on ice for 5 min, and
the white slurry was filtered.Then, 5% (w/v) aq. Na2SO3 (40 mL/g alkene) was added and
stirred at RT for 15 min, after which the phases were separated. The aqueous layer was
extracted two times with CH2Cl2. The combined organic layers were washed with sat. aq.
NaHCO3 (1×) and brine (1×), dried over Na2SO4, and filtered before solvent removal by
evaporation. The epoxides were purified by column chromatography using a mixture of
cyclohexane/ethyl acetate, 95:5. The identity and purity of the epoxides (isolated yields of
40–60%) was confirmed by NMR, and the resulting NMR data were consistent with the
literature data [58].
3.3. Chemical Synthesis of Azidoalcohol Standards
First, 1 mmol of either trans-2,3-epoxyhexane (2) (100 mg) or trans-2,3-epoxyheptane
(5) (114 mg) was mixed with 202 mg of NaN3 (3.1 eq.) and 166 mg of NH4Cl (3.1 eq.)
in 3.5 mL of methanol and refluxed until no more substrate was visible on TLC (5–6 h).
Then, the reaction mixture was diluted in diethyl ether, washed with brine, and the water
phase was extracted twice with diethyl ether. The organic layers were combined and
dried over Na2SO4. The crude extracts were purified by column chromatography with
cyclohexane/diethyl ether (90:10), yielding 52% azido-hydroxyhexane (3) and 48% azido-
hydroxyheptane (6) [59]. The identity and purity of obtained azidoalcohols was confirmed
by NMR, and the resulting NMR data were consistent with literature data [42].
3.4. Bacterial Strains and Plasmids
The Escherichia coli DH5α strain (Invitrogen, Carlsbad, CA, USA) was used for plasmid
amplification and DNA manipulation, while E. coli BL21 (DE3) (Novagen, EMD Biosciences,
San Diego, CA, USA) was used for all heterologous expressions.
The vector pMK-RQ containing the codon-optimised genes coding for StyA and StyB
was obtained from Invitrogen (Thermo Fisher Scientific division, Wilmington, USA). Genes
styA and styB were cloned into MCS1 and MCS2, respectively, of the expression vector
pETDuet-1. In particular, styA was inserted between NcoI and BamHI restriction sites,
whereas styB was inserted between XhoI and NdeI restriction sites.
The synthetic alcohol dehydrogenase gene from Leisfonia sp. S749 (LsADH) was
ordered cloned in vector pCDF1Duet-1 (Genscript, NJ, USA), whereas LkADH was readily
available in vector pET21a(+).
The HHDH genes were readily available in pET28a(+)-based vectors [41].
3.5. Biocatalyst Production
Heterologous protein production was performed in 400 mL of TB media (2 L shake
flask) with addition of the respective antibiotic(s) (Table 4). A 5 mL overnight culture
of the respective E. coli strain was used to inoculate a 50 mL pre-culture in TB media
(250 mL flask). The cells were grown at 37 ◦C and 200 rpm until they reached an OD600
of approximately 2–4. Then, the main culture (400 mL) was inoculated with a required
volume of the pre-culture to reach a starting OD600 of 0.1. The cells in the main culture were
grown at 37 ◦C and 200 rpm until they reached OD600 of 0.8–1.2, when 0.2 mM isopropyl-β-
D-thiogalactopyranoside (IPTG) was added as an inducer, and the expression temperature
was lowered to 20 ◦C. Expression was performed overnight. Cells were harvested by
centrifugation at 7000× g for 30 min at 4 ◦C, and cell pellets were washed and stored at
−20 ◦C until further use. In experiments where cell-free extract was used, cell pellets were
resuspended in 50 mM potassium phosphate buffer pH 7.5 to a concentration of 0.60 g/mL,
and cell disruption was performed via sonication (6 cycles of 30 s at an amplitude of 50%,
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with 30 s pause on ice between cycles). Cell debris was removed by centrifugation at
33,000× g for 30 min at 4 ◦C. Glycerol (20% final concentration) was added to the resulting
cell-free extract before storage at −20 ◦C.
Table 4. List of vectors and corresponding antibiotics used in this work.
Vectors Antibiotics (Final Conc.)
pETDuet-styAB, Ampicillin (100 µg/mL)
pET21a(+)-LkADH Ampicillin (100 µg/mL)
pCDF1Duet-LsADH Spectinomycin (100 µg/mL)
pETDuet-styAB, pET21a(+)-LkADH Kanamycin (50 µg/mL), Ampicillin (100 µg/mL)
pETDuet-styAB, pCDF1Duet-LsADH Kanamycin (50 µg/mL), Spectinomycin (100 µg/mL)
pET28a(+)-hhdh from the E-type Kanamycin (50 µg/mL)
3.6. Epoxidation Catalysed by the Unspecific Peroxygenase from Agrocybe aegerita
Cell-free extract harbouring the unspecific peroxygenase from A. aegerita (42 µM) was
applied to test for trans-2-heptene (4) epoxidation using a modified literature protocol [60].
The enzyme concentration was adjusted to 100 nM in 50 mM potassium phosphate buffer
pH 7.5, 4 was added from a 500 mM stock in ethanol to a final concentration of 20 mM.
Finally, H2O2 was added drop-wise over 8 h to a final concentration of 100 mM (5 eq.).
After 24 h at 30 ◦C and at 900 rpm shaking, an aliquot was extracted according to the
sample preparation protocol described previously.
3.7. StyAB-Catalysed Epoxidation—1 mL Scale
Cell-free extract of E. coli BL21(DE3) containing StyAB was diluted in 50 mM potassium
phosphate buffer, pH 7.5 to reach a final total protein concentration of 9.2 g/L. Then, 5 mM
substrate (1 or 4) was added, and the commercial formate dehydrogenase from C. boidinii
(0.5 U/mL) was added together with 150 mM sodium formate for cofactor regeneration.
After 24 h, samples were taken and analysed by GC.
3.8. StyAB-Catalysed Epoxidation—80 mL Scale
Epoxidations using CFE of E. coli BL21 (DE3) harbouring StyAB and LsADH at a
final concentration of 9.2 g/L (total protein content) were carried out in 50 mM potassium
phosphate buffer at pH 7.5 in a final volume of 80 mL. Trans-2-hexene (1) or trans-2-heptene
(4) was added to a concentration of 50 mM from a 2 M stock in isopropanol (used as
co-substrate for NADH regeneration). Compressed air was provided through an HPLC frit
with a flow of 3 L/h. The reaction was mechanically stirred with overhead stirring for 24 h
at 25 ◦C. At fixed time points, samples were taken and analysed by GC.
Epoxidations with substrate feeding: Substrate was manually fed 5 times every hour
using an appropriate amount of the 2 M stock in isopropanol until the final 50 mM concen-
tration was reached.
Epoxidations with enzyme feeding: Enzyme feeding was performed manually every
hour for the first 5 h of reaction by addition of an appropriate amount of the stock CFE
solution (75 g/L total protein content) until the final concentration of 9.2 g/L (total protein
content) was reached.
If an organic phase was present, the total volume was kept to 80 mL split in 60 mL of
50 mM potassium phosphate buffer at pH 7.5 and 20 mL of organic phase. Substrate was
fed on the organic phase, whereas cell-free extract was fed into the aqueous phase using
a syringe and a needle. The reaction was monitored via GC analysis by taking samples
directly from the organic phase by processing it as described below.
3.9. Jacobsen Epoxidation—1 mL Scale
The Jacobsen catalyst is generally designed for the epoxidation of terminal alkenes,
but as it was readily available, it was tested with alkene 4 using the standard protocol [16].
To 10 mM of trans-2-heptene (4) in 1 mL saturated NaHCO3 pH 8.0 at room temperature,
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0.2 equivalents of either (R,R)- or (S,S)-Jacobsen’s catalyst were added. Then, 2 equivalents
of NaOCl were added in portions to support the epoxidation. After 24 h incubation
at 900 rpm shaking, a sample of 400 µL was taken, extracted, and analysed by GC as
described below.
3.10. Shi epoxidation
The typical Shi epoxidation was performed in either 1, 20, or 50 mL scale using
different acetonitrile concentrations (5%, 10%, and 20% v/v). The test reaction was carried
out in ddH2O in a final volume of 2 mL. Then, 2 mM of the Shi epoxidation catalyst were
used to convert 10 mM of alkene 4 using 2 equivalents of Oxone©, which were added in
portions over the first 2 h, at room temperature for 24 h at 900 rpm shaking. NaHCO3
was added to maintain the pH at 8.0. Optimisation reactions were carried out in 20 or
50 mL scale using K2CO3 to maintain the pH at 11. Different concentrations of alkene 1 or
4 were used in combination with 0.2 equivalents of the Shi epoxidation diketal catalyst and
4 equivalents of Oxone©, which were added in portions over the first 8 h together with
K2CO3 to keep the pH constant. At fixed time points, samples were taken and analysed
by GC.
3.11. HHDH-Catalysed Epoxide Ring-Opening
Whole cells (60 g/L wet cell weight) of E. coli BL21(DE3) harbouring the HHDHs
from the E-type were used to convert 10 mM of epoxide 2 or 5, respectively. Then, 50 mM
of NaN3 were added as nucleophile, and the reaction was carried out in 1 mL in 50 mM
potassium phosphate buffer with 600 rpm shaking at 25 ◦C. Generally, after 4 h and 24 h,
samples were taken and analysed by GC.
3.12. HHDH—Compatibility Tests
Compatibility test studies were performed as described above using either whole
cells (60 g/L wet cell weight) or CFE (9.2 g/L total protein content) of E. coli BL21(DE3)
harbouring HheE or HheE5 converting 10 mM of epoxide 2 or 5, respectively. The influence
of heptane (25% v/v) on HheE and HheE5, applied as whole-cell biocatalyst with 60 g/L
wet cell weight, was tested in 3 mL 50 mM potassium phosphate buffer at pH 7.5. The
reaction volume was increased to have enough volume to sample directly from the organic
phase. Then, 10 mM substrate (2 or 5) and 50 mM sodium azide (NaN3) were added, and
the solution was magnetically stirred at 25 ◦C and 600 rpm. After 4 h and 24 h of reaction,
samples were taken for GC analysis.
The influence of acetonitrile (5%, 10%, or 20% v/v) and Oxone© (10 mM) on the
HHDHs was tested in 4 mL of 50 mM potassium phosphate buffer at pH 7.5. Then, 10 mM
substrate (2 or 5 for HheE and HheE5, respectively) and 40 mM sodium azide (NaN3) were
added and the solution was magnetically stirred at 25 ◦C and 600 rpm. After 4 h and 24 h
of reaction, samples were taken for GC analysis.
3.13. Cascade 1—Shi Epoxidation Diketal Catalyst, HHDH—One-Pot Two-Step Mode
In the one-pot two-step cascade run, the Shi epoxidation was carried out at −2 ◦C
in 45 mL ddH2O with 5 mL of acetonitrile (10% v/v). Then, 0.2 equivalents of Shi epoxi-
dation diketal catalyst were used to convert 50 mM of alkene 1 or 4. Four equivalents of
Oxone© were added in portions over the first 8 h together with solid K2CO3 to maintain
a pH of 11. After incubation for 24 h at 300 rpm, the temperature was adjusted to 25 ◦C
before lowering the pH to 7.5 using 95 % H2SO4. After this, whole cells (60 g/L wet cell
weight) of E. coli harbouring HheE or HheE5 were added together with 50 mM of NaN3,
and the reaction was continued for an additional 24 h. After 48 h of total reaction time
(step 1 + step 2), NaCl was added until saturation. Afterwards, the reaction mixture was
extracted 4 times with TBME. For better phase separation, a short centrifugation step (2 min
at 2900× g) was performed. The combined organic phases were dried over anhydrous
Na2SO4, and the solvent was removed under reduced pressure. The resulting crude (2S,3R)-
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2-azido-3-hydroxyhezane (3a) or (2S,3R)-2-azido-3-hydroxyheptane (6a) were purified as
described in the section chemical synthesis of azidoalcohol standards.
3.14. Cascade 2—StyAB, HHDH—One-Pot Two-Step Mode
The epoxidation of 50 mM of either trans-2-hexene (2) or trans-2-heptene (4) was
carried out in 60 mL of 50 mM potassium phosphate buffer, pH 7.5, and 20 mL of heptane.
The reaction was mechanically stirred at 300 rpm in a water bath at 30 ◦C with compressed
air input (3 L/h). CFE harbouring StyAB and LsADH as well as the substrate (as 2 M
stock in isopropanol) were added hourly for the first 8 h to final concentrations of 9.2 g/L
total protein content and 50 mM, respectively. After 24 h, whole cells (60 g/L wet cell
weight) of E. coli harbouring HheE or HheE5 and 50 mM of sodium azide were added in
one portion to start the epoxide ring-opening reaction. After another 24 h of reaction (48 h
of total reaction time), NaCl was added until saturation. Afterwards, the reaction mixture
was extracted 4 times with TBME. For better phase separation, a short centrifugation
step (2 min at 2900× g) was performed. The combined organic phases were dried over
anhydrous Na2SO4, and the solvent was removed under reduced pressure. The resulting
crude (2R,3S)-2-azido-3-hydroxyheptane (3a) or (2R,3S)-2-azido-3-hydroxyheptane (6a)
were purified as described in the section chemical synthesis of azidoalcohol standards.
3.15. Sample Preparation for GC Analysis
Samples taken from the aqueous reaction mixture were extracted with an equal volume
of TBME or ethyl acetate containing each 0.1% (v/v) dodecane as internal standard. The
organic phase was dried over anhydrous sodium sulphate and submitted to GC analysis. If
a second organic phase was used (i.e., heptane) or the reaction was performed in an organic
solvent, the sample was taken directly from the organic phase, dried over anhydrous
sodium sulphate, and submitted to GC analysis.
3.16. GC Analysis
GC analyses have been performed on a Shimadzu GC2010 plus gas chromatograph
with an FID detector using different chiral and achiral columns and hydrogen as carrier gas.
The injector and detector temperature were set to 300 ◦C for achiral measurements, whereas
they were set to 200 ◦C and 250 ◦C respectively for chiral measurements. A summary of
the applied temperature programs and columns can be found in Table 5. Conversions of
substrate into the corresponding products were determined by achiral GC based on relative
peak areas or with a calibration curve. Enantiomeric excesses (ee) of azidoalcohol products
3a and 6a were determined using chiral GC according to a literature protocol [61].
Table 5. Temperature programs and columns used for analysis of the different compounds on achiral or chiral GC as well as
resulting retention times.
Compound Temperature Profile RT (min) Column
trans-2-hexene (1)
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Table 5. Cont.
Compound Temperature Profile RT (min) Column
(2S,3R)-2-azido-3-hydroxyhexane (3a)















The aim of this work was to expand the range of accessible enantiopure azidoalco-
hols through a combination of alkene epoxidation and subsequent epoxide azidolysis, as
recently reported for the generation of styrene-based azidoalcohols [12]. Here, we have
demonstrated that this strategy can be extended to linear non-terminal alkene substrates,
giving access to a broader range of possible azidoalcohol products. Due to the high regios-
electivity of the applied halohydrin dehalogenases for epoxide ring opening and very low
chemical background reaction, final azidoalcohol products were obtained with very high
to excellent regioselectivity, resulting in high product purities. Moreover, the identification
of stereocomplementary epoxidation catalysts even enabled us to synthesise opposite
azidoalcohol enantiomers, albeit epoxide enantiopurity in the Shi epoxidation reaction
requires further improvement. Alternatively, recently discovered (R)-selective styrene
monooxygenases could be used in the future to obtain respective (2S,3R)-azidoalcohols
with high enantiomeric excess [31–33].
With this, our approach nicely adds to existing synthetic routes and already accessible
azidoalcohol products. With an additional simple hydrogenation step to reduce the azido
group to an amino group, our cascade will further offer access to corresponding chiral
aminoalcohols [62–64].
Our attempts of running both cascades at synthetically meaningful substrate concen-
trations (50 mM) also revealed current limitations that need to be addressed by enzyme and
reaction engineering in the future to harness the full potential of our proposed cascades.
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